RecruitingNCT05468008

Endoscopic Submucosal Dissection (ESD)

Prospective Evaluation of the Clinical Utility of Endoscopic Submucosal Dissection (ESD) in Western Population


Sponsor

AdventHealth

Enrollment

1,000 participants

Start Date

Feb 4, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating a minimally invasive procedure called Endoscopic Submucosal Dissection (ESD), which allows doctors to remove tumors from the lining of the digestive tract without open surgery. **You may be eligible if...** - You have been diagnosed with an early-stage tumor or pre-cancerous lesion in the stomach, esophagus, colon, or rectum - Your doctor has determined that ESD is an appropriate treatment for your condition - You are able to provide informed consent **You may NOT be eligible if...** - Your tumor is too large or deeply invasive for this procedure - You have a serious bleeding disorder or are on blood thinners that cannot be safely stopped - You are not a suitable candidate for endoscopic procedures due to other health conditions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndoscopic Submucosal Dissection

Endoscopic submucosal dissection (ESD) is an outpatient procedure to remove deep tumors from the gastrointestinal (GI) tract


Locations(1)

AdventHealth Orlando

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05468008


Related Trials